SAN DIEGO--(BUSINESS WIRE)--Jul. 29, 2009-- Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today that the company's SynCon TM H1N1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results